Clinical Trials Browser

Recurrence × apatinib × Gastrointestinal × Clear all

NCT03913182 2020-02-05

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis, Recurrence

NCT03026881 2017-03-07

A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients

Phase 1 Unknown

Gastrointestinal

Recurrence, Stomach Neoplasms